Genenta Science (NASDAQ:GNTA)
@GenentaScience
Genenta is a clinical stage immuno oncology-company
You might like
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET @pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake @SergioAbrignani @niaforg @NucleateHQ @issnaf @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
@GenentaScience $GNTA New Coverage Update by @ROTHCapital - BUY - TP $15
@GenentaScience @Nasdaq $GNTA on #INNLIFES by #MichelaMoretti @NaldiniLab @AssobiotecNews @SIMEST_IT @clusteralisei @Cluster_LLS innlifes.com/biotech/paracc…
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET @pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake @SergioAbrignani @niaforg @NucleateHQ @issnaf @assoiotecnews @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
"Strategico avere sperimentazioni cliniche e pre-cliniche in Italia per impatto rilevante sulla vita di tutti noi. Alla base dello sviluppo di una nuova #terapia ci sono le #imprese, grandi ma anche medio-piccole". Il nostro consigliere @pigiparacchi live: bit.ly/42VmfKS
Nucleate welcomes this conversation on connecting international biotech investors and founders in Italy. We thank our Nucleate Italy and @pigiparacchi for organizing.
thanks for taking part of Innovit for Life Sciences! @Assobiotec @pigiparacchi @NucleateHQ
Da un'idea alla quotazione in borsa: quella di @GenentaScience è la storia di un vero caso di successo. Al #SIOS23 Summer ci sarà @pigiparacchi, CEO e co-founder di Genenta Science (Nasdaq: $GNTA) Registrati👉 bit.ly/43c3FPk Main partner @SACEgroup in collab. @UniLUISS
@GenentaScience $GNTA at #SIOS23 @startup_italia in Rome on 27th @UniLUISS @ProfPrencipe @SACEgroup @INNOVUPnet @AssobiotecNews @SIMEST_IT @Assolombarda @NaldiniLab @clusteralisei @Cluster_LLS $XBI #biotech
@GenentaScience $GNTA tomorrow with @AssobiotecNews #OneHealth @OdcecMilano odcec.mi.it/eventi/2023/06…
thanks for taking part of Innovit for Life Sciences! @Assobiotec @pigiparacchi @NucleateHQ
Join the the first fireside chat #InnovitforLifeSciences that brings together the competitiveness of 🇮🇹 Life Sciences 🩺and the experience of 🇺🇸 Investors 🎆 Registration: bit.ly/27June23 @GenentaScience @NIH
Join us for a live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investors. Innovit for Life Sciences > Road to #JPM24 On Tuesday 27th June 2023 10.30am EDT - 4.30pm CET @GenentaScience @AssobiotecF
Join us June 22, 7.30pm live at POLIMI – Graduate School of Management with @pigiparacchi CEO @GenentaScience eventbrite.com/e/biglietti-pa…
eventbrite.com
Paving the Way for a better Future
Investing, nurturing, and growing Biotech and Sustainable companies.
@GenentaScience is at Sidoti Virtual Event May 10 2023 with our @pigiparacchi CEO and Co-founder , join us
See these #healthcare management teams present live and submit your questions during their Q&A. $ACU $CYTO $ANPC $BXRX $CRDL $COYA $HUGE $GNTA $GNPX $HILS $HUMA $INFU $IKT $KTRA ow.ly/fqFJ30svfWR All investors are welcome to join free of charge: ow.ly/KCPS30svfWS
True or False: Cell therapy refers to the transfer of autologous or allogeneic cellular material into a patient for medical purposes
4 vote · Final results
Our lead candidate is a lenti-virus based hematopoietic stem progenitor cell #immunotherapy enabling controlled and targeted interferon-α expression within #cancers. Learn more: bit.ly/3VGjoT3
At Genenta, our scientists bring a unique blend of multi-disciplinary competence, vast experience in #CellTherapy, and a commensurate track-record in the forefront of therapies and #DrugDevelopment. Learn more: bit.ly/40xHqBL
Meet Richard B. Slansky, Chief Financial Officer at Genenta! Richard is a senior financial executive with more than 30 years of experience at various #biopharmaceutical diagnostic and life science companies. Learn more: bit.ly/3ZV3yGf
We're #hiring a new Genenta Science VP Business Development based in New York, New York, United States. Apply today or share this post with your network linkedin.com/feed/update/ur…
Our platform technology triggers the production of alpha-interferon as a therapeutic inside the tumors through a transgene expression control vector, allowing for a robust anti-cancer response with potential minimized systemic toxicity. Check out our MOA: bit.ly/3FXShxs
United States Trends
- 1. Indiana N/A
- 2. Prince Andrew N/A
- 3. Board of Peace N/A
- 4. Woody N/A
- 5. Toy Story 5 N/A
- 6. Arlington Heights N/A
- 7. Punch N/A
- 8. Soldier Field N/A
- 9. Kevin Warren N/A
- 10. Jace N/A
- 11. Hera N/A
- 12. Sunday Night Baseball N/A
- 13. #NattyMerch N/A
- 14. Gemini 3.1 Pro N/A
- 15. Wolf Lake N/A
- 16. Runaway N/A
- 17. MING-NA N/A
- 18. The UK N/A
- 19. Pritzker N/A
- 20. King Charles N/A
You might like
-
pierluigi paracchi
@pigiparacchi -
Hemant Taneja
@htaneja -
Farmindustria
@FarmindustriaTW -
Mergermarket
@Mergermarket -
Sachin H. Jain, MD, MBA
@sacjai -
CorriereBuoneNotizie
@CorriereBN -
Jay Bradner, M.D.
@jaybradner -
Riot Platforms, Inc.
@RiotPlatforms -
MEDIA INAF
@mediainaf -
D-Wave
@dwavequantum -
Università Vita-Salute San Raffaele
@MyUniSR -
Pink Sheet, Citeline Regulatory
@PharmaPinkSheet -
Exos
@TeamEXOS -
Satellogic
@Satellogic -
BioPharma Dive
@BioPharmaDive
Something went wrong.
Something went wrong.